1329 related articles for article (PubMed ID: 11923602)
1. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
2. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the treatment response of HCC.
Kim KW; Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
Tiong L; Maddern GJ
Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.
Pleguezuelo M; Germani G; Marelli L; Xiruochakis E; Misseri M; Manousou P; Arvaniti V; Burroughs AK
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):761-84. PubMed ID: 19090737
[TBL] [Abstract][Full Text] [Related]
6. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
Young S; Golzarian J
AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691
[No Abstract] [Full Text] [Related]
7. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
Hong K; Georgiades CS; Geschwind JF
Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatocellular carcinoma.
Nakakura EK; Choti MA
Oncology (Williston Park); 2000 Jul; 14(7):1085-98; discussion 1098-102. PubMed ID: 10929592
[TBL] [Abstract][Full Text] [Related]
9. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
Salhab M; Canelo R
J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
[TBL] [Abstract][Full Text] [Related]
10. Interventional radiology for hepatocellular carcinoma.
Loffroy R
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
[TBL] [Abstract][Full Text] [Related]
11. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
Tung-Ping Poon R; Fan ST; Wong J
Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
[TBL] [Abstract][Full Text] [Related]
12. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
13. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
Xu Z; Xie H; Zhou L; Chen X; Zheng S
Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
[TBL] [Abstract][Full Text] [Related]
14. [Locally ablative therapies of hepatocellular carcinoma].
Sturm JW; Keese MA; Bönninghoff RG; Wüstner M; Post S
Onkologie; 2001 Sep; 24 Suppl 5():35-45. PubMed ID: 11600811
[TBL] [Abstract][Full Text] [Related]
15. Combined interventional therapies of hepatocellular carcinoma.
Qian J; Feng GS; Vogl T
World J Gastroenterol; 2003 Sep; 9(9):1885-91. PubMed ID: 12970869
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for hepatocellular carcinoma.
Sandhu DS; Tharayil VS; Lai JP; Roberts LR
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for hepatocellular carcinoma.
Nishikawa H; Kimura T; Kita R; Osaki Y
Int J Hyperthermia; 2013 Sep; 29(6):558-68. PubMed ID: 23937321
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
Huo TI; Huang YH; Wu JC
J Chin Med Assoc; 2005 Apr; 68(4):155-9. PubMed ID: 15850062
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.
Chen L; Sun J; Yang X
Cancer Lett; 2016 Jan; 370(1):78-84. PubMed ID: 26472630
[TBL] [Abstract][Full Text] [Related]
20. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
